626 Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $466K | Sell |
10,072
-154
| -2% | -$7.13K | 0.22% | 66 |
|
|
2025
Q1 | $624K | Buy |
10,226
+173
| +2% | +$10.6K | 0.32% | 51 |
|
|
2024
Q4 | $569K | Buy |
10,053
+699
| +7% | +$39.5K | 0.31% | 55 |
|
|
2024
Q3 | $484K | Sell |
9,354
-60
| -0.6% | -$3.1K | 0.27% | 61 |
|
|
2024
Q2 | $391K | Sell |
9,414
-375
| -4% | -$15.6K | 0.23% | 71 |
|
|
2024
Q1 | $531K | Sell |
9,789
-876
| -8% | -$47.5K | 0.32% | 56 |
|
|
2023
Q4 | $547K | Sell |
10,665
-40
| -0.4% | -$2.05K | 0.36% | 50 |
|
|
2023
Q3 | $621K | Sell |
10,705
-249
| -2% | -$14.5K | 0.42% | 50 |
|
|
2023
Q2 | $701K | Sell |
10,954
-218
| -2% | -$13.9K | 0.45% | 42 |
|
|
2023
Q1 | $774K | Sell |
11,172
-87
| -0.8% | -$6.03K | 0.51% | 44 |
|
|
2022
Q4 | $810K | Buy |
11,259
+11
| +0.1% | +$791 | 0.56% | 41 |
|
|
2022
Q3 | $800K | Buy |
11,248
+11
| +0.1% | +$782 | 0.65% | 37 |
|
|
2022
Q2 | $864K | Buy |
11,237
+11
| +0.1% | +$846 | 0.65% | 32 |
|
|
2022
Q1 | $820K | Sell |
11,226
-141
| -1% | -$10.3K | 0.53% | 42 |
|
|
2021
Q4 | $709K | Buy |
+11,367
| New | +$709K | 0.43% | 44 |
|
|
2021
Q1 | $820K | Buy |
+11,226
| New | +$820K | 0.53% | 42 |
|